Ribosomal surveillance pathways scan for ribosomes that are transiently paused or terminally stalled owing to structural elements in mRNAs or nascent chain sequences 1, 2 . Some stalls in budding yeast are sensed by the GTPase Hbs1, which loads Dom34, a catalytically inactive member of the archaeo-eukaryotic release factor 1 superfamily. Hbs1-Dom34 and the ATPase Rli1 dissociate stalled ribosomes into 40S and 60S subunits. However, the 60S subunits retain the peptidyl-tRNA nascent chains, which recruit the ribosome quality control complex that consists of Rqc1-Rqc2-Ltn1-Cdc48-Ufd1-Npl4. Nascent chains ubiquitylated by the E3 ubiquitin ligase Ltn1 are extracted from the 60S subunit by the ATPase Cdc48-Ufd1-Npl4 and presented to the 26S proteasome for degradation [3] [4] [5] [6] [7] [8] [9] . Failure to degrade the nascent chains leads to protein aggregation and proteotoxic stress in yeast and neurodegeneration in mice [10] [11] [12] [13] [14] . Despite intensive investigations on the ribosome quality control pathway, it is not known how the tRNA is hydrolysed from the ubiquitylated nascent chain before its degradation. Here we show that the Cdc48 adaptor Vms1 is a peptidyl-tRNA hydrolase. Similar to classical eukaryotic release factor 1, Vms1 activity is dependent on a conserved catalytic glutamine. Evolutionary analysis indicates that yeast Vms1 is the founding member of a clade of eukaryotic release factor 1 homologues that we designate the Vms1-like release factor 1 clade.
. Some stalls in budding yeast are sensed by the GTPase Hbs1, which loads Dom34, a catalytically inactive member of the archaeo-eukaryotic release factor 1 superfamily. Hbs1-Dom34 and the ATPase Rli1 dissociate stalled ribosomes into 40S and 60S subunits. However, the 60S subunits retain the peptidyl-tRNA nascent chains, which recruit the ribosome quality control complex that consists of Rqc1-Rqc2-Ltn1-Cdc48-Ufd1-Npl4. Nascent chains ubiquitylated by the E3 ubiquitin ligase Ltn1 are extracted from the 60S subunit by the ATPase Cdc48-Ufd1-Npl4 and presented to the 26S proteasome for degradation [3] [4] [5] [6] [7] [8] [9] . Failure to degrade the nascent chains leads to protein aggregation and proteotoxic stress in yeast and neurodegeneration in mice [10] [11] [12] [13] [14] . Despite intensive investigations on the ribosome quality control pathway, it is not known how the tRNA is hydrolysed from the ubiquitylated nascent chain before its degradation. Here we show that the Cdc48 adaptor Vms1 is a peptidyl-tRNA hydrolase. Similar to classical eukaryotic release factor 1, Vms1 activity is dependent on a conserved catalytic glutamine. Evolutionary analysis indicates that yeast Vms1 is the founding member of a clade of eukaryotic release factor 1 homologues that we designate the Vms1-like release factor 1 clade.
Yeast Cdc48, an AAA + (ATPases associated with diverse cellular functions) ATPase that is conserved across eukaryotes and archaea, is a protein unfoldase 15, 16 that engages in myriad cellular functions through the binding of adaptors such as Ufd1-Npl4, which bind both Cdc48 and ubiquitylated substrate proteins. A protein A-based 'non-stop' substrate reporter (PrANS) encoded by an mRNA lacking a stop codon (Fig. 1b) accumulates on the ribosomal 60S subunit as a ubiquitylated species linked to tRNA when Cdc48 or Ufd1-Npl4 function is compromised 7 , suggesting that Cdc48-Ufd1-Npl4 somehow extracts the ubiquitylated nascent chain from the 60S tunnel [6] [7] [8] . Two pieces of evidence implicated Vms1, which contains a Cdc48-binding VIM motif 17, 18 , in the ribosome quality control (RQC) pathway. First, vms1∆ and RQC-deficient mutations cause a synthetic growth defect when combined with mutations that impair degradation of nonstop mRNA 8, 19 . Second, vms1∆ 18 mutants, like rqc2∆
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, are sensitive to cycloheximide treatment. We extended this by showing that vms1∆, like ltn1∆ (LTN1 is also known as RKR1) and cdc48 7 , displayed sensitivity to hygromycin, which binds the decoding centre (Extended Data Fig. 1a) .
To investigate further the role of Vms1 in the degradation of nonstop proteins, we examined PrANS levels. PrANS conjugated to tRNA (PrANS-tRNA) accumulated in vms1∆ cells, but not in mutants lacking other Cdc48 adaptors (Fig. 1c) . Additionally, vms1∆ cells accumulated high molecular mass forms of PrANS. Treatment with RNase or deubiquitylase enzymes (Extended Data Fig. 1c ) and pull-downs with ubiquitin-binding TUBE resin (Extended Data Fig. 1d ) confirmed that high molecular mass PrANS species were tRNA-linked ubiquitin conjugates (Ub-PrANS-tRNA).
Splitting of stalled 80S ribosomes is a prerequisite for the stable association of Ltn1 with 60S subunits. Ltn1 then ubiquitylates the nascent chains before their degradation by 26S proteasomes 21 . To determine whether Ub-PrANS-tRNA accumulated on 60S subunits in vms1∆ cells, we fractionated cell lysates on sucrose gradients. Immunoblotting for PrANS and the 60S protein Rpl3 revealed that Ub-PrANS-tRNA accumulated maximally in the first few Rpl3-containing fractions, which marks the position of 60S subunits 7 ( Fig. 1d) . By contrast, non-ubiquitylated PrANS-tRNA that accumulated in both vms1∆ and vms1∆ltn1∆ cells was enriched on 80S subunits and polysomes. These data confirm that Ub-PrANS-tRNA accumulated on 60S subunits in vms1∆ in a manner that was dependent on Ltn1.
If Vms1 is directly involved in releasing stalled PrANS, it should bind ribosomes. To investigate this prediction, we immunoblotted sucrose gradient fractions from cells expressing Vms1 tagged with a triple haemagglutinin epitope (Vms1-HA3). Ltn1 is restricted to 60S fractions 4 , whereas Vms1-HA3 was detected across the entire gradient (Fig. 1e) . This behaviour suggests a broader function for Vms1 beyond its role in the RQC pathway. Notably, the 60S peak of Vms1-HA3 was diminished and shifted towards lighter fractions in ltn1∆ cells (Fig. 1e) , suggesting that in addition to Cdc48-Ufd1-Npl4 6 , Ltn1 also promotes the recruitment of Vms1 to 60S subunits. However, unlike Cdc48-Ufd1-Npl4, Vms1 was not identified as a component of the RQC complex 6 . Consistent with this, Vms1 did not associate directly with Ufd1-Npl4 (Extended Data Fig. 1e-h ).
Given the exceptionally strong accumulation of PrANS-tRNA in vms1∆ mutants, we wondered whether Vms1 might have any relationship to known peptidyl-tRNA hydrolases. We carried out sensitive iterative sequence profile searches with PSI-BLAST and hidden Markov models seeded with the core RNase H fold domain of the archaeal and eukaryotic release factor 1 (RF1) proteins and the catalytically inactive Dom34 proteins, which are both members of the archaeo-eukaryotic RF1 (aeRF1) superfamily (see 'Computational analyses' in Methods). Notably, these searches recovered the central globular region of Vms1 orthologues. Reciprocal PSI-BLAST searches with this region recovered several members of the aeRF1 superfamily. This relationship was confirmed with a profile-profile comparison using the HHpred program with an alignment of the central conserved region of Vms1 run against the Protein Data Bank (PDB) database, which significantly recovered human eRF1 (PDB accession number 1DT9; P = 4 × 10
−5
). This showed that the central domain of Vms1 had a putative catalytic loop bearing a conserved glutamine comparable to the classic active site of aeRF1 proteins (Fig. 2a, b ). An aeRF1-like topology was observed in the recently reported crystal structure of the middle domain of Vms1, but the putative active-site loop was not resolved 22 . The conserved glutamine in the eRF1 protein coordinates a water molecule in the A site at the peptidyl transferase centre (PTC). Nucleophilic attack of the peptidyl-tRNA in the P site by this water molecule releases the completed polypeptide chain 23, 24 . In addition to the glutamine in the putative active site, Vms1 also contains conserved vicinal arginines Letter reSeArCH in the α-helix immediately following the active-site loop (Fig. 2a, b) . Equivalent arginines in eRF1 have been implicated in the stabilization of the active-site loop 23 , and stimulation of GTPase eRF3 25 . Based on these similarities, we designated Vms1 as the founding member of the Vms1-like release factor 1 (VLRF1) clade within the aeRF1 superfamily. In addition to the eukaryotic orthologues of Vms1, the VLRF1 clade also contains members from certain bacteria, predominantly bacteroidetes and more divergent versions in certain Archaea (Extended Data Fig. 2a, b) .
To verify that Vms1 is a novel peptidyl-tRNA hydrolase we generated two separate point mutations (Q295L and Q295P) of the predicted catalytic glutamine, which abrogate eRF1 function in budding yeast 23 and bacterial release factors 26 , respectively. We also generated a putative active site deletion mutant (∆AS). All mutant proteins were expressed normally and bound ribosomes (Fig. 3a) . Whereas wild-type Vms1-HA3 rescued vms1∆, cells expressing the point mutants accumulated PrANS-tRNA (Fig. 3a, left) , which sedimented with ribosomes ( Fig. 3a , middle) and was conjugated to ubiquitin (Fig. 3a, right) . Sucrose gradient fractionation confirmed that Ub-PrANS-tRNA accumulated on 60S subunits in cells expressing Vms1-Q295L-HA3 (Fig. 3b) . Notably, the mutant protein strongly accumulated on 60S subunits, and was depleted from low molecular mass fractions (Fig. 3c) . Consistent with their biochemical defect, the vms1
Q295L
, vms1 Q295P and vms1 ∆AS mutants were extremely sensitive to hygromycin and cycloheximide (Fig. 3d) . The point mutants thus phenocopy vms1∆, both genetically and biochemically.
The putative catalytic region of Vms1 and other VLRF1 proteins is flanked by additional N-and C-terminal domains. The N-terminal C2H2-type zinc-finger of Vms1 is specifically related to those of Rei1 and certain SBDS paralogues, which function late in 60S subunit maturation 27 . This suggests that Vms1 might contact the ribosome with its Rei1-like zinc-finger domain (Fig. 2c) . Meanwhile, the Vms1 C-terminal region is characterized by a run of three ankyrin repeats, a treble-clef fold zinc-binding domain (VTC; lost in fungi) and a VIM motif that binds Cdc48 17, 18 (Fig. 2c) . To probe the role of these other sequence features, we generated mutants including DNKR (lacking four Rei1-like zinc-finger residues predicted to interact with the 60S subunit; see legend to Extended Data Fig. 3c for details), RR (lacking the conserved vicinal arginines in the catalytic domain) and ∆VIM, and expressed the proteins in a vms1∆ strain. All mutant proteins were expressed comparably to wild type (Extended Data Fig. 3a) . To assess the effects of the mutations, we performed sucrose gradient fractionation of ribosomes. Compared to vms1∆ rescued by wild-type VMS1 HA3 , all mutants accumulated Ub-PrANS-tRNA in 60S fractions (Extended Data Fig. 3c ). The RR mutant exhibited the strongest accumulation, as well as conspicuous spreading of Ub-PrANS-tRNA into the 80S peak, which was also observed with the ∆VIM mutant. Notably, the DNKR mutant protein was shifted to lighter fractions, with depletion from monosome and polysome fractions, consistent with a role for the zinc-finger in binding ribosomes (Extended Data Fig. 3d) . Notably, the cycloheximide sensitivity of the various mutants mimics the data obtained with the reporter, with the ∆AS and RR mutants being most sensitive (Extended Data Fig. 3b) .
To address conclusively the hypothesis that Vms1 is a novel peptidyl-tRNA hydrolase, we sought to reconstitute peptidyl-tRNA hydrolytic activity in vitro. Polyhistidine (His6) tags were added to the N-terminus of wild-type Vms1 and the Vms1-Q295L mutant. The proteins were then expressed in bacteria and purified (Extended Data Fig. 4a ). For the substrate, we used 60S fractions from vms1∆ cells expressing PrANS. Recombinant Vms1 and the substrate were mixed, and after incubation, peptidyl-tRNA was precipitated using hexadecyl-trimethyl-ammonium bromide (CTAB). His6-Vms1 promoted the release of both Ub-PrANS-tRNA and PrANS-tRNA species from 60S subunits (Fig. 4a) . By contrast, His6-Vms1-Q295L was unable to release modified substrate. This assay was reproducible but required extensive manipulations that resulted in spontaneous hydrolysis of the substrate during its preparation. In addition, it was difficult to reliably quantify heterogeneous ubiquitin conjugates by immunoblot. Therefore, we turned to in vitro translation in rabbit reticulocyte lysate, which has been used to reconstitute ubiquitylation of RQC substrates 9, 21 . These earlier studies demonstrated that ubiquitylation of the nascent chain is delayed by approximately 15 min after translation. Because the Vms1-dependent reaction (Fig. 4a) did not display strong dependence on substrate ubiquitylation, we ran brief translation reactions with a non-stop template encoding Flag-tagged CRP with a 30-nucleotide poly(A) tail (Flag-CRPNSKn) to generate stalled nascent chains that had not yet been ubiquitylated, which simplified quantification. The major translation product (Fig. 4b ) was confirmed to be tRNAconjugated Flag-CRPNSKn using CTAB precipitation and RNase treatment (Extended Data Fig. 4b ). Consistent with a previous report 9 , the stalled Flag-CRPNSKn-tRNA was associated maximally with 80S fractions (Extended Data Fig. 4c ).
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To assay for eRF1-like peptidyl-tRNA hydrolytic activity, wild-type or mutant His6-Vms1 was incubated with 35 S-labelled substrate for increasing periods of time (Fig. 4b) . De-acylation of Flag-CRPNSKntRNA with concomitant formation of unmodified substrate was observed within three minutes (Fig. 4b, c) and at concentrations as low as 25 nM His6-Vms1 (Fig. 4d , quantified in Extended Data Fig. 4d ), whereas essentially no hydrolysis above background was observed with His6-Vms1-Q295L. Because recombinant yeast Vms1 was functional in this heterologous system, we next tested ANKZF1, the human Vms1 orthologue. Purified ANKZF1 (Extended Data Fig. 4a ) catalysed deacylation, whereas the active site mutant ANKZF1-Q246L was inactive ( Fig. 4e and Extended Data Fig. 4e) .
Like vms1∆ mutants, cdc48 mutant cells accumulate Ub-PrANStRNA on 60S subunits 7 . This raises the question as to what the role of Cdc48 is in the hydrolysis of peptidyl-tRNA. We were unable to establish ATP-dependence for the in vitro deacylation reaction (data not shown), which perhaps is not surprising because the ATPase Rli1 accelerates nascent chain release by eRF1 in the presence of nonhydrolysable ATP 5 . We suggest that Cdc48 facilitates presentation of the catalytic glutamine of Vms1 at the PTC, much as Rli1 positions Fig. 3c ). Cdc48 ATPase working together with Ltn1 may have an additional role at the exit tunnel after deacylation. The emerging nascent chain is ubiquitylated by Ltn1, which recruits Cdc48-Ufd1-Npl4 6, 7 . The latter can then translocate along and unfold the nascent chain 15, 16 thereby ensuring its extraction from the 60S subunit. In other contexts, different factors may facilitate nascent chain clearance. For example, defective ribosome-nascent chain complexes targeted to mitochondria become stuck during import 29 . Vms1 promotes clearance of these stalls in a VIM-independent manner. Owing to close apposition of the stalled ribosome-nascent chain and mitochondrial translocon 29 , neither Ltn1 nor Cdc48-Ufd1-Npl4 should gain access to the deacylated nascent chain to ensure its extraction. Vms1 also localizes to the endoplasmic reticulum and the RQC pathway can rescue nascent chains that are stalled at the Sec61 translocon 30 .
Three observations point to an additional role for Vms1 in the release of stalled nascent chain-tRNA from intact ribosomes, which is also likely to be Ltn1-independent: (i) Vms1 associates with all forms of ribosomes and this persists in ltn1∆ (Fig. 1e) , (ii) vms1 mutant cells exhibited strong accumulation of PrANS-tRNA in both monosome and polysome fractions (Figs. 1d and 3b) , and (iii) Low doses (Fig. 4d ) of Vms1 rapidly (Fig. 4b ) deacylated peptidyl-tRNA that was associated with the 80S ribosome. Nascent chain-engaged 60S subunits can, however, re-associate with free 40S subunits in vitro to generate 80S ribosome-nascent chain complexes 21 . We suggest that in vivo, the leading stalled ribosome on non-stop poly(A) mRNA that has its A site occupied could be the monosome substrate for Vms1 (see Extended Data Fig. 5 for model) . Cleavage by an unidentified endonuclease generates ribosomes with empty A sites on truncated mRNA that are known to be rescued by Dom34-Hbs1-Rli1 1 . Jammed nascent chain-tRNA on these split 60S subunits is ubiquitylated by Ltn1 and the tRNA linkage is hydrolysed by Vms1. Our Letter reSeArCH discovery of Vms1 as the founding member of the VLRF1 clade reveals that multiple different functional peptidyl-tRNA hydrolase release factors belonging to the aeRF1 superfamily coexist in eukaryotic cells. We posit that VLRF1 and Dom34 evolved to protect the translation apparatus from errors in transcription and post-transcriptional processing that generate defective mRNAs.
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Yeast strains and culture conditions. All strains used in the current study are listed in Extended Data Table 1 . They were derived from W303 or S288C backgrounds and grown as described 7 . Western blot analyses. The following antibodies were used: PAP (Sigma, P1291), anti-Flag M2 (Sigma, F-1804), anti-TAP (Thermo Fisher, CAB1001) and anti-HA 3F10 (Roche/Sigma, 12013819001). Anti-Rpl32 and -Rpl3 antibodies were a gift from J. Warner. Ribosome isolation and sub-fractionation. The sucrose cushion method for the isolation of ribosomes; the binding of ribosomal preparations to TUBE-UBA resin; sucrose density gradient centrifugation; and CTAB precipitation of peptidyl-tRNA from sucrose gradient fractions were performed as previously described 7 . TUBE resin was purchased from Boston Biochem (AM-130). CTAB was purchased from Sigma (52365). Site-directed mutagenesis. All expression constructs for mutational analysis were generated using the Q5-Site-Directed Mutagenesis Kit (NEB E00554S) following the manufacturer's instructions. Primers were designed using the online tool NEBaseChanger (http://nebasechanger.neb.com). Mutations were confirmed by Sanger sequencing. All plasmids are listed in Extended Data Table 1 . Purification of His6-Vms1 and His6-Vms1-Q295L from bacteria. Wild-type and mutant Vms1 (Extended Data Table 1 ) were cloned into the bacterial pET-28a vector in frame with the N-terminal His6 tag. Expression was induced in Rosetta cells using 1 mM IPTG at 16 °C for 16 h. Cell pellets were brought up in lysis buffer containing 50 mM Hepes, pH 8.0, 0.5 M NaCl, 20 mM imidazole and 0.5% Triton, sonicated, and centrifuged at 34,000g for 20 min in a Sorvall SS34 rotor. Supernatant was bound to Ni-NTA affinity resin (Qiagen) for 1 h at 4 °C. Bound proteins were washed four times in lysis buffer and eluted in 25 mM Hepes, pH 7.5, 150 mM NaCl, 5% glycerol and 250 mM imidazole. Imidazole was removed by dialysis and proteins were concentrated using Amicon Ultra centrifugal filters. Purification of ANKZF1-Flag-Myc and ANKZF1(Q246L)-Flag-Myc. Plasmids were constructed that contained the cytomegalovirus (CMV) promoter followed by sequences encoding wild-type (Origene) or Q246L ANKZF1 (current study; confirmed by sequencing) tagged with a Flag-Myc epitope sequence at the 3′ end of the open reading frame. These constructs were transiently transfected into human embryonic kidney HEK293 cells (ATCC, tested negative for mycoplasma contamination). After 72 h, proteins were purified using a previously published protocol for Flag-tagged mammalian proteins 21 . In vitro transcription and translation. PCR products were generated using 3×Flag-CRP (Extended Data Table 1 ) as a template with the reverse primer either containing a stop codon (3×Flag-CRPStop), or lacking a stop codon but with a 30-nucleotide poly(T) extension (3×Flag-CRPNSKn). PCR products were transcribed and translated in vitro using TnT T7 Quick rabbit reticulocyte lysate (Promega, L5540) in the presence of radioactive methionine (Perkin Elmer, NEG709A). Reactions were typically for 30 min at 30 °C, at which time recombinant proteins were added for another 10 min. Aliquots were resolved by SDS-PAGE, and dried gels were exposed either to film or to a PhosphorImager screen. Isolation of tandem affinity purification-tagged complexes from yeast. Cells in which CDC48, VMS1 or UFD1 were tagged at the 3′ end with the tandem affinity purification (TAP) epitope sequence 31 were grown to exponential phase in 2 l YPD medium and collected. Washed cell pellets were ground in liquid nitrogen, and the powder was resuspended in a lysis buffer containing 25 mM Tris, pH 7.5, 150 mM NaCl, 0.25% Triton and protease inhibitor tablets (Roche, 11873580001) at a ratio of two volumes of powder to one volume of buffer. Following centrifugation at 34,000g for 20 min (Sorvall SS34 rotor), lysates were bound to 200 μl acid-washed IgG sepharose 6 Fast Flow (GE Healthcare, 17-0969-01) at 4 °C for 90 min. Bound proteins were washed twice in lysis buffer, twice in TEV buffer (25 mM Tris, pH 7.5, 150 mM NaCl, 2 mM dithiothreitol, 5% glycerol) and eluted by cleavage with 50 U TEV for 2 h at 16 °C. Mass spectrometry analyses. Eluted samples were lyophilized and digested for mass spectrometry analysis as described 32 . Approximately 250 ng of trypsin-digested peptides were loaded onto a 26-cm analytical HPLC column (75-μm inner diameter) packed in-house with ReproSil-Pur C 18AQ 1.9-μm resin (120 Å pore size; Dr. Maisch). Once loaded, the peptides were separated with a 120-min gradient at a flow rate of 350 nl min −1 at 50 °C (column heater) using the following gradient: 2-6% solvent B (7.5 min), 6-25% B (82.5 min), 25-40% B (30 min), 40-100% B (1 min) and 100% B (9 min), in which solvent A was 97.8% H 2 O, 2% acetonitrile and 0.2% formic acid, and solvent B was 19.8% H 2 O, 80% acetonitrile and 0.2% formic acid. Samples were analysed using an EASY-nLC 1000 coupled to an Orbitrap Fusion operated in data-dependent acquisition mode to automatically switch between a full scan (m/z = 350-1,500) in the Orbitrap at 120,000 resolving power and a tandem mass spectrometry scan of higher-energy collisional dissociation fragmentation that was detected in the ion trap (using TopSpeed).
The automatic gain control targets of the Orbitrap and ion trap were 400,000 and 10,000, respectively. Mass spectrometry data analysis. All raw data were searched concurrently using MaxQuant (v.1.5.3.30 33, 34 ) against the Saccharomyces Genome Database (SGD) and a common contaminant database. Precursor mass tolerance was 4.5 p.p.m. after automatic recalibration. Fragment ion tolerance was 0.5 Da. Searches permitted up to two missed tryptic peptide cleavages. Cysteine carbamidomethylation was designated as a fixed modification while methionine oxidation and N-terminal acetylation were designated as variable modifications. Intensity-based absolute quantification (iBAQ) protein quantification and 'match between runs' were enabled. Protein and peptide false discovery rates were estimated to be less than 1% using a target-decoy approach. Computational analyses. Iterative sequence profile searches were performed using the PSI-BLAST 35 and JACKHMMER 36 programs run against the NCBI nonredundant protein database clustered at 50% identity using the MMseqs2 program. Similarity-based clustering for both classification and culling of nearly identical sequences was performed using the BLASTCLUST program (ftp://ftp.ncbi.nih.gov/ blast/documents/blastclust.html). The length (L) and score (S) threshold parameters were variably adjusted depending on need. For example, the length and score threshold parameters for clustering near identical proteins were L = 0.9 and S = 1.2. The HHpred program was used for profile-profile searches 37 . Structure similarity searches were performed using the DaliLite program 38 . Multiple sequence alignments were made using the Kalign program followed by manual adjustments on the basis of profile-profile searches and structural alignments 39 . Secondary structures were predicted using the JPred program 40 . For previously known domains, the Pfam database 41 was used as a guide, although the profiles were augmented by addition of newly detected divergent members that were not detected by the original Pfam models. Clustering with BLASTCLUST combined with multiple sequence alignment and further sequence profile searches were used to identify other domains that were not present in the Pfam database. Contextual information from prokaryotic gene neighbourhoods was retrieved by a Perl script that extracts the upstream and downstream genes of the query gene and uses BLASTCLUST to cluster the proteins to identify conserved gene-neighbourhoods. Phylogenetic analysis was conducted using an approximately-maximum-likelihood method implemented in the FastTree 2.1 program under default parameters 42 . Structural visualization and manipulations were performed using the PyMol v. Supplementary Fig. 1 . Source Data for quantifications in Fig. 4 and Extended Data Fig. 4 are provided in the online version of the paper. All other data supporting the findings of this study are available from the corresponding authors upon reasonable request. Fig. 2 | Vms1 is the founding member of the VLRF1 clade. a, Extended sequence alignment of aeRF1 superfamily with representatives from all families and clades (compared to the limited subset shown in Fig. 2a) . b, Phylogenetic tree depicting relationships within the aeRF1 superfamily; colouring matches clade labels in Fig. 2a . In the classical aeRF1 clade, two branches contain eukaryotic orthologues (eRF1) and archaeal orthologues (aRF1), respectively. Of the bacterial (baeRF1) versions, certain members are misannotated as 'Host_attach' in the Pfam database while most cannot be detected by existing profiles. The total number of prokaryotic representatives of the VLRF1 clade in the non-redundant database (NCBI, as of 1 December 2017) is 1,044. Of these, the archaeal VLRF1 family (aVLRF1) has 279 members, actinochloroflexi VLRF1 family (acVLRF1) has 669 and the bacteroidetes VLRF1 family (bVLRF1) has 96. Notable domain architectures and conserved gene neighbourhoods are shown to the right of tree. A gene encoding a ribosome hibernation factor (HPF-like or YfiA-like) that facilitates inactive ribosome aggregation frequently co-occurs and is predicted to function with the baeRF1 domains. The labels below the architecture diagrams list the well-characterized clade representatives, PDB structure accessions and phyletic distributions. The dashed outline indicates domains that are not universally present. 
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Data exclusions
Describe any data exclusions.
No data was excluded from the analyses.
Replication
Describe whether the experimental findings were reliably reproduced.
All findings have been replicated twice (western blots and PhosphorImager analyses), or thrice (spot viability assays).
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Not relevant to the current study. There were no experimental groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The experimenter was aware of the identity of the samples being analyzed. Blinding was not relevant in the current study since the Figures show the raw data from the experiments and thus the reader can directly assess the accuracy of the interpretations by the experimenter.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
